Flinton Capital Management LLC trimmed its position in UnitedHealth Group (NYSE:UNH) by 1.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 184,464 shares of the healthcare conglomerate’s stock after selling 1,960 shares during the period. UnitedHealth Group comprises about 1.4% of Flinton Capital Management LLC’s portfolio, making the stock its 14th largest holding. Flinton Capital Management LLC’s holdings in UnitedHealth Group were worth $40,667,000 at the end of the most recent reporting period.
Other hedge funds have also recently bought and sold shares of the company. KBC Group NV boosted its holdings in UnitedHealth Group by 4.7% in the 3rd quarter. KBC Group NV now owns 323,799 shares of the healthcare conglomerate’s stock worth $63,416,000 after buying an additional 14,672 shares during the last quarter. DekaBank Deutsche Girozentrale boosted its holdings in UnitedHealth Group by 2.0% in the 3rd quarter. DekaBank Deutsche Girozentrale now owns 489,647 shares of the healthcare conglomerate’s stock worth $95,646,000 after buying an additional 9,810 shares during the last quarter. Toronto Dominion Bank boosted its holdings in UnitedHealth Group by 12.6% in the 4th quarter. Toronto Dominion Bank now owns 432,508 shares of the healthcare conglomerate’s stock worth $95,350,000 after buying an additional 48,565 shares during the last quarter. Bainco International Investors boosted its holdings in UnitedHealth Group by 5.4% in the 3rd quarter. Bainco International Investors now owns 82,676 shares of the healthcare conglomerate’s stock worth $16,192,000 after buying an additional 4,202 shares during the last quarter. Finally, GWM Advisors LLC boosted its holdings in UnitedHealth Group by 20.3% in the 4th quarter. GWM Advisors LLC now owns 9,297 shares of the healthcare conglomerate’s stock worth $2,090,000 after buying an additional 1,571 shares during the last quarter. Institutional investors own 86.73% of the company’s stock.
UNH has been the topic of several research analyst reports. Goldman Sachs initiated coverage on UnitedHealth Group in a report on Wednesday, January 3rd. They issued a “buy” rating and a $269.00 price objective on the stock. Evercore ISI reiterated an “outperform” rating and issued a $255.00 price objective (up from $235.00) on shares of UnitedHealth Group in a report on Friday, January 12th. Cantor Fitzgerald reiterated a “buy” rating and issued a $235.00 price objective on shares of UnitedHealth Group in a report on Tuesday, January 16th. Piper Jaffray restated a “buy” rating and set a $259.00 target price on shares of UnitedHealth Group in a report on Wednesday, January 17th. Finally, Royal Bank of Canada boosted their target price on UnitedHealth Group from $269.00 to $280.00 and gave the stock an “outperform” rating in a report on Wednesday, January 17th. Three investment analysts have rated the stock with a hold rating and twenty-five have issued a buy rating to the stock. The stock has an average rating of “Buy” and a consensus price target of $253.70.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, April 17th. The healthcare conglomerate reported $3.04 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.91 by $0.13. The firm had revenue of $55.19 billion for the quarter, compared to analyst estimates of $54.90 billion. UnitedHealth Group had a net margin of 5.41% and a return on equity of 22.06%. The business’s revenue for the quarter was up 13.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.37 EPS. analysts forecast that UnitedHealth Group will post 12.61 earnings per share for the current year.
In other news, CEO Steven H. Nelson sold 14,233 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, March 15th. The shares were sold at an average price of $230.22, for a total transaction of $3,276,721.26. Following the sale, the chief executive officer now owns 18,219 shares of the company’s stock, valued at approximately $4,194,378.18. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Michele J. Hooper sold 10,000 shares of the business’s stock in a transaction that occurred on Wednesday, January 31st. The shares were sold at an average price of $237.76, for a total value of $2,377,600.00. Following the completion of the sale, the director now directly owns 37,284 shares in the company, valued at approximately $8,864,643.84. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 82,019 shares of company stock worth $18,928,333. Corporate insiders own 0.89% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.